The Italian daily newspaper La Repubblica writes about our lead product denovoSkin™ being used to treat a child in Milan, Italy.
The young child suffered severe burns over a large portion of his body due to a domestic accident. Traditional skin grafts were not a viable option due to his young age and the extent of the injuries.
This patient is now part of the ongoing pediatric clinical trial aimed at demonstrating the efficacy and safety of denovoSkin™ in young kids, who represent a particularly challenging demographic in burn surgery due to their delicate skin and rapid growth rates.
A twin study in adolescents and adults has completed recruitment, and safety and efficacy has been recently demonstrated (read the press release here). A third study in reconstructive surgery has completed recruitment (read the press release here).
In the article, Professor Gloria Pelizzo, who led the surgical team, noted the successful grafting of our personalized, bioengineered skin graft, highlighting the potential for denovoSkin™ to significantly improve outcomes in pediatric burn treatment.
We extend a big thank you to Italian patients, surgeons and investors for being part of CUTISS’ journey.
